• Asker Healthcare Group agreed to buy 100% of Baltic medtech distributor Ambercell Solutions.
• Ambercell supplies procedure-specific packs and consumables via a proprietary supply-chain platform across Lithuania, Latvia, and Estonia.
• The business has 45 employees. Revenue was about SEK 250 million in the past year.
• Closing is expected in Q4, subject to regulatory approval. The deal is expected to lift Asker’s EBITA margin.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asker Healthcare Group AB published the original content used to generate this news brief via Cision (Ref. ID: 202608190130BITN____UKPR__EN_20260819-BIT-9287-0) on August 19, 2026, and is solely responsible for the information contained therein.